This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Abbott failing to supply FTC merger data because of 'buyer's remorse,' Alere suit says

By Flavia Fortes ( August 31, 2016, 21:35 GMT | Insight) -- Diagnostic device provider Alere alleged in a lawsuit that Abbott Laboratories is purposefully failing to supply information about their $5.8 billion merger to antitrust authorities in the US and abroad in an effort to sabotage the agreement because of “buyer’s remorse.” Alere is seeking to compel Abbott to take all actions necessary, in a timely manner, to secure antitrust approval.Diagnostic device provider Alere alleged that Abbott Laboratories is purposefully failing to supply information about their $5.8 billion merger to antitrust authorities in the US and abroad, in an effort to sabotage the agreement because of “buyer’s remorse.”...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login